Skip to main content
Camlin Fine Sciences Ltd logo

Camlin Fine Sciences Ltd — Investor Relations & Filings

Ticker · CAMLINFINE ISIN · INE052I01032 LEI · 3358005CR8R9MY6DLY36 BSE.NS Manufacturing
Filings indexed 1,525 across all filing types
Latest filing 2019-11-09 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS CAMLINFINE

About Camlin Fine Sciences Ltd

https://www.camlinfs.com

Camlin Fine Sciences Ltd is a global provider of specialty chemicals, specializing in shelf-life extension solutions and aroma ingredients. The company is a leading manufacturer of traditional antioxidants, including Tertiary Butylhydroquinone (TBHQ) and Butylated Hydroxyanisole (BHA), which are utilized to maintain the stability and quality of food, feed, and industrial applications. Its product portfolio also features aroma chemicals such as vanillin and ethyl vanillin, supported by a vertically integrated manufacturing process. Camlin Fine Sciences serves a broad range of sectors, including human nutrition, animal health, pet food, pharmaceuticals, and fragrances. By utilizing advanced chemical synthesis and a global distribution network, the company delivers performance chemicals and customized blends designed to enhance product longevity and sensory characteristics.

Recent filings

Filing Released Lang Actions
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding compliance under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. It encloses the extract of unaudited financial results for the quarter ended September 30, 2019, published in newspapers. The content includes financial data for a quarter, specifically unaudited quarterly financial results, which is typical of an Interim / Quarterly Report. The document is about quarterly financial results and contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2019-11-09 English
Outcome of Board Meeting
Regulatory Filings
2019-11-08 English
Financial Result Updates
Regulatory Filings
2019-11-08 English
Outcome of Board Meeting held on 8th November, 2019
Regulatory Filings
2019-11-08 English
Unaudited Financial Results for 30th September, 2019
Regulatory Filings
2019-11-08 English
Investors Conference Call - Intimation
Regulatory Filings
2019-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.